Multiple Sclerosis Trial, Recruiting

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

• People diagnosed with relapsing-remitting multiple sclerosis (a form of MS with flare-ups followed by recovery periods), based on the 2017 McDonald diagnostic criteria, who are more than 6 months past their last relapse or progressive period
• People whose level of disability falls within a specific range on the Expanded Disability Status Scale (EDSS), scoring between 5 and 6.5 (a standard MS disability measurement scale) — confirm with trial site if unsure what this means for a particular situation
• People who are currently living at home
• People who use a walking aid to get around
• People aged 18 or older
• People who have freely agreed to take part in the study
• People who are taller than 1 metre 52 centimetres
• People who have a certain minimum level of muscle strength in the hips and knees, as measured by standard physiotherapy testing (confirm with trial site)
• People who score above 20 on the Berg Balance Scale, a standard test of balance ability
• People who are enrolled in, or covered by, a French social security plan

Who may not be able to join:

• People whose ability to understand instructions is too limited to follow the study procedures
• People who are unable to walk without assistance for at least 10 minutes
• People who have a planned rehabilitation stay scheduled during the study follow-up period
• People with a diagnosed psychiatric condition that could be affected by stopping use of the assistive device at the end of the study
• People with severe cognitive impairment, defined as scoring below 24 on the MMSE (a standard memory and thinking test)
• People who are currently deprived of their liberty by a court or administrative decision
• People currently receiving psychiatric care, or living in a health or social care institution for reasons other than research
• People with significant muscle stiffness (spasticity) above a certain level in specific leg muscles, as measured by a standard clinical scale
• People with complete paralysis of both legs
• People with severe osteoporosis (very low bone density)
• People with hip or knee replacements that significantly limit their ability to move, walk, sit, or squat
• People with severe blood vessel (vascular) problems in the legs
• People with existing wounds or skin problems in the areas where the device would be worn
• People who are pregnant, or who have recently given birth and have not completed pelvic floor and lower back recovery
• People with bone or joint conditions in the legs that would prevent the Keeogo device from being properly fitted
• People with epilepsy or tremors that are not well controlled
• People with uncontrolled autonomic dysreflexia (a condition involving sudden changes in the nervous system's automatic functions)
• People with severe balance or neurological disorders that would prevent safe control of balance and movement while wearing the Keeogo device
• People with any condition that makes moderate-intensity exercise unsafe

Important: Always verify eligibility with the trial site directly before applying.